Have a personal or library account? Click to login
Use of codeine and NSAID combination in rhinogenic headache Cover

Use of codeine and NSAID combination in rhinogenic headache

Open Access
|Nov 2019

References

  1. 1. Taylor FR. Diagnosis and classification of headache. Prim Care. 2004;31(2):243–59, v.10.1016/j.pop.2004.02.002
  2. 2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646–57.1155495210.1046/j.1526-4610.2001.041007646.x
  3. 3. Foroughipour M, Sharifian SM, Shoeibi A, Ebdali Barabad N, Bakhshaee M. Causes of headache in patients with a primary diagnosis of sinus headache. Eur Arch Otorhinolaryngol. 2011;268(11):1593-6. DOI: 10.1007/s00405-011-1643-6. Epub 2011 May 31.10.1007/s00405-011-1643-6.Epub201131
  4. 4. Herzallah IR, Hamed MA, Salem SM, Suurna MV. Mucosal contact points and paranasal sinus pneumatization: Does radiology predict headache causality? Laryngoscope. 2015;125(9):2021-6. DOI: 10.1002/lary.25194. Epub 2015 Feb 25.10.1002/lary.25194.Epub2015Feb25
  5. 5. Kim SH. A case of nasal septal deviation-induced rhinogenic contact point otalgia. Am J Otolaryngol. 2015;36(3):451-5. DOI: 10.1016/j.amjoto.2015.01.008. Epub 2015 Jan 14.10.1016/j.amjoto.2015.01.008.Epub201514
  6. 6. Ziegler DK. Opioids in headache treatment. Is There a role? Neurol Clin. 1997;15(1):199-207.10.1016/S0733-8619(05)70304-2
  7. 7. Burgos-Vega C, Moy J, Dussor G. Meningeal afferent signaling and the pathophysiology of migraine. Prog Mol Biol Transl Sci. 2015;131:537-64. DOI: 10.1016/bs.pmbts.2015.01.001. Epub 2015 Feb 9.10.1016/bs.pmbts.2015.01.001.Epub2015Feb9
  8. 8. Ambrosini A, D’Alessio C, Magis D, Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. Cephalalgia. 2015;35(14):1308-22. DOI: 10.1177/0333102415573511. Epub 2015 Mar 3.10.1177/0333102415573511
  9. 9. Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12. DOI: 10.3389/fneur.2015.00012.eCollection 2015.10.3389/fneur.2015.00012.eCollection2015
  10. 10. Eren Y, Dirik E, Neșelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg. 2015;115(4):643-9. DOI: 10.1007/s13760-015-0427-y. Epub 2015 Jan 17.10.1007/s13760-015-0427-y
  11. 11. Dussor G. ASICs as therapeutic targets for migraine. Neuropharmacology. 2015;94:64-71. DOI: 10.1016/j.neuropharm.2014.12.015. Epub 2015 Jan 9.10.1016/j.neuropharm.2014.12.015.Epub20159
  12. 12. Arruda MA, Arruda R, Guidetti V, Bigal ME. Psychosocial adjustment of children with migraine and tension-type headache - a nationwide study. Headache. 2015;55 Suppl 1:39-50. DOI: 10.1111/head.12510. Epub 2015 Feb 6.10.1111/head.12510.Epub2015Feb6
  13. 13. Domingues RB, Duarte H, Rocha NP, Teixeira AL. Reduced serum levels of adiponectin in tension-type headache. Clin Neurol Neurosurg. 2015;131:82-5. DOI: 10.1016/j.clineuro.2015.01.026. Epub 2015 Feb 7.10.1016/j.clineuro.2015.01.026.Epub2015Feb7
  14. 14. Bayraktutan OF, Demir R, Ozel L, Ozdemir G, Ertekin A. Prevalence of tension-type headache in individuals aged between 18-65 years in the Eastern Parts of Turkey. Eurasian J Med. 2014;46(2):78-83. DOI: 10.5152/eajm.2014.20.10.5152/eajm.2014.20
  15. 15. Cady RK, Schreiber CP. Sinus headache: a clinical conundrum. Otolaryngol Clin North Am. 2004;37(2):267–88.10.1016/S0030-6665(03)00181-6
  16. 16. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005;25(6):460-5.10.1111/j.1468-2982.2005.00878.x
  17. 17. Cukurova I, Cetinkaya EA, Demirhan E, Avci A. Long-term histological examination of inferior concha after radiofrequency thermal ablation. J Laryngol Otol. 2011;125(2):158-61. DOI: 10.1017/S0022215110001532. Epub 2010 Aug 23.10.1017/S0022215110001532.Epub2010Aug23
  18. 18. Cady RK, Dodick DW, Levine HL, Schreiber CP, Eross EJ, Setzen M, et al. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005;80(7):908-16.10.4065/80.7.908
  19. 19. Pipolo C, Portaleone S, Felisati G. Nose and headache: what have we learned? Naso e cefalee: cosa abbiamo imparato. Neurol Sci. 2011;32(Suppl1):S131-3. DOI: 10.1007/s10072-011-0531-6.10.1007/s10072-011-0531-6
  20. 20. Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl. 1988;134:3-23.10.1177/00034894880970S501
  21. 21. Cady RK, Schreiber CP. Sinus headache or migraine? considerations in making a differential diagnosis. Neurology. 2002;58(9 Suppl 6):S10-4.10.1212/WNL.58.9_suppl_6.S10
  22. 22. Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–54.10.1146/annurev.me.44.020193.001045
  23. 23. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23(2):193–6.245406610.1002/ana.410230214
  24. 24. Schreiber CP. The pathophysiology of primary headache. Prim Care. 2004;31(2):261–76, v-vi.10.1016/j.pop.2004.03.001
  25. 25. Becker DE. Pain Management: Part 1: Managing acute and postoperative dental pain. Anesth Prog. 2010;57(2):67-79. DOI: 10.2344/0003-3006-57.2.67.10.2344/0003-3006-57.2.67
  26. 26. Bley KR, Hunter JC, Eglen RM, Smith JA. The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci. 1998;19(4):141–7.10.1016/S0165-6147(98)01185-7
  27. 27. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclo-oxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 1996;390(2):165–9.10.1016/0014-5793(96)00604-7
  28. 28. Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol. 1999;128(6):1121-32. DOI: 10.1038/sj.bjp.0702897.10.1038/sj.bjp.0702897
  29. 29. Martin WR. General problems of drug abuse and drug dependence. In: Martin WR (eds). Drug Addiction I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology (Heffter-Heubner / New Series), vol 45 / 1. Springer, Berlin, Heidelberg; 1977, p.3-40. DOI: https://doi.org/10.1007/978-3-642-66612-4_1.10.1007/978-3-642-66612-4_1
  30. 30. Jasinski DR. Assessment of the abuse potentiality of the morphine like drugs (Methods Used in Man). In: Martin WR (eds). Drug Addiction I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology (Heffter-Heubner / New Series), vol 45 / 1. Springer, Berlin, Heidelberg; 1977, p.197-258. DOI: https://doi.org/10.1007/978-3-642-66612-4_4.10.1007/978-3-642-66612-4_4
  31. 31. Sarne Y, Fields A, Keren O, Gafni M. Stimulatory Effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochem Res. 1996;21(11):1353-61.10.1007/BF02532376
  32. 32. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261(15):2211-6.10.1001/jama.1989.03420150061038
  33. 33. Zhang WY, Po AL. Do codeine and caffeine enhance the analgesic effect of aspirin?–A systematic overview. J Clin Pharm Ther. 1997;22(2):79-97.937380710.1111/j.1365-2710.1997.tb00002.x
DOI: https://doi.org/10.2478/rjr-2019-0021 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Language: English
Page range: 165 - 169
Submitted on: Jul 15, 2019
|
Accepted on: Aug 21, 2019
|
Published on: Nov 1, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Cemal Cingi, Erdem Atalay Cetinkaya, Osman Halid Cam, Fatih Oghan, Nuray Bayar Muluk, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.